Biotech ETFs Pop as Bristol-Myers Squibb Set to Acquire Celgene

Posted on: January 3, 2019 by in Blog
No Comments

Biotechnology sector-related exchange traded funds strengthened Thursday after Bristol-Myers Squibb (NYSE: BMY) agreed to acquire rival CelgeneĀ …

Leave a Reply

You must be logged in to post a comment.